Cargando…
Identification of therapeutic drugs against COVID-19 through computational investigation on drug repurposing and structural modification
Global prevalence of coronavirus disease 2019 (COVID-19) calls for an urgent development of anti-viral regime. Compared with the development of new drugs, drug repurposing can significantly reduce the cost, time, and safety risks. Given the fact that coronavirus harnesses spike protein to invade hos...
Autores principales: | Yun, Yangfang, Song, Hengyi, Ji, Yin, Huo, Da, Han, Feng, Li, Fei, Jiang, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718070/ https://www.ncbi.nlm.nih.gov/pubmed/33122473 http://dx.doi.org/10.7555/JBR.34.20200044 |
Ejemplares similares
-
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing
por: Bernal, Leonardo, et al.
Publicado: (2023) -
Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis
por: Rajput, Akanksha, et al.
Publicado: (2021) -
Advances in the computational landscape for repurposed drugs against COVID-19
por: Aronskyy, Illya, et al.
Publicado: (2021) -
Target RNA modification for epigenetic drug repositioning in neuroblastoma: computational omics proximity between repurposing drug and disease
por: Ma, Pei, et al.
Publicado: (2020) -
A review of computational drug repurposing
por: Park, Kyungsoo
Publicado: (2019)